National Health (Growth Hormone Program) Special Arrangement 2015
10Definitions relating to doses of somatropin
Start here
Get a plain-English read of 10
Turn the raw legal text into a practical explanation grounded in National Health (Growth Hormone Program) Special Arrangement 2015.
10 Definitions relating to doses of somatropin
(1) For the purposes of table items 1 to 4 of the table in section 11:
dose, for a person and a pharmaceutical benefit, means a dose of pharmaceutical benefit mentioned in the table in section 11 that is measured as a dose that applies to the body surface area of the person for a week, with the body surface area of the person calculated using the formula:
Start formula body surface area equals start square root start fraction height in cm times weight in kg over 3600 end fraction end square root end formula
(2) For the purposes of table items 1 to 3 of the table in section 11, the measurement ‘m2’ refers to: (a) where a person is: (i) mentioned in item 1 or 2 in the table in section 11; or (ii) mentioned in item 3 in the table in section 11 and has a body mass index less than the 85th percentile for age and sex; a square metre of the body surface area of the person calculated by weight; or (b) where a person is: (i) mentioned in item 3 in the table in section 11; and (ii) has a body mass index greater than the 85th percentile for age and sex, a square metre of the body surface area of the person, calculated using ideal body weight (kg). (3) For the purposes of table item 4 of the table in section 11, the measurement ‘kg’ refers to: (a) where a person is mentioned in item 4 in the table in section 11 and has a body mass index equal to or less than the 85th percentile for age and sex, the person’s body weight in kilograms; or (b) where a person is mentioned in item 4 in the table in section 11 and has a body mass index greater than the 85th percentile for age and sex, the person’s ideal body weight in kilograms.